Digestive & Intestinal Remedies (Pharmacies) - Nigeria

  • Nigeria
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$101.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 10.08%, resulting in a market volume of US$148.90m by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.44 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Nigeria has experienced significant growth in recent years, driven by changing customer preferences, emerging trends, and local special circumstances. Customer preferences in Nigeria have shifted towards a greater focus on health and wellness, leading to an increased demand for digestive and intestinal remedies. Consumers are becoming more conscious of their diet and lifestyle choices, and are seeking products that can help them maintain a healthy digestive system. As a result, there has been a growing interest in natural and herbal remedies, as well as probiotics and other supplements that promote gut health. In addition to changing customer preferences, several trends have emerged in the Digestive & Intestinal Remedies market in Nigeria. One of the key trends is the rise of e-commerce and online pharmacies. With the increasing penetration of smartphones and internet access, more consumers are turning to online platforms to purchase healthcare products, including digestive and intestinal remedies. This trend has been further accelerated by the COVID-19 pandemic, as consumers have sought to minimize physical contact and reduce the risk of exposure to the virus. Another trend in the market is the growing awareness and adoption of traditional medicine. Nigeria has a rich tradition of herbal medicine, and many consumers are turning to traditional remedies for digestive and intestinal issues. This trend is supported by the availability of traditional medicine practitioners and the growing acceptance of alternative therapies. Local special circumstances also play a role in shaping the Digestive & Intestinal Remedies market in Nigeria. The country has a large population, with a significant proportion of the population experiencing digestive and intestinal issues. This creates a substantial market opportunity for pharmaceutical companies and healthcare providers. Furthermore, Nigeria has a growing middle class with increased disposable income, enabling more consumers to afford healthcare products and services. Underlying macroeconomic factors also contribute to the development of the Digestive & Intestinal Remedies market in Nigeria. The country has experienced steady economic growth in recent years, leading to an improvement in living standards and increased healthcare spending. Additionally, the government has implemented healthcare reforms and initiatives to improve access to healthcare services, including pharmaceutical products. In conclusion, the Digestive & Intestinal Remedies market in Nigeria is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As consumers become more health-conscious and seek natural remedies, the demand for digestive and intestinal remedies is expected to continue growing. The rise of e-commerce and online pharmacies, as well as the adoption of traditional medicine, are also shaping the market. With a large population and a growing middle class, Nigeria presents a significant market opportunity for pharmaceutical companies operating in the Digestive & Intestinal Remedies sector.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)